Literature DB >> 17356277

Merits and problems in high-threshold methadone maintenance treatment. Evaluation of medication-assisted rehabilitation in Norway 1998-2004.

Helge Waal1.   

Abstract

BACKGROUND: Methadone maintenance treatment (MMT) in Norway emphasizes rehabilitation and control with strict intake criteria and rules for involuntary termination. Consequently, the programme should be characterized as high threshold and restrictive, which is somewhat out of tune with the general European trend towards harm reduction and diversity.
METHODS: The programme has undergone an extensive evaluation with quantitative and qualitative methods.
FINDINGS: MMT is at present integrated into the general health and social security system. The restrictive traits have not prevented rapid development in the capacity and coverage. Results on retention and drug use are above average for MMT programmes, but results on vocational rehabilitation are not impressive. The system is costly and some inherent structural problems cause concern.
CONCLUSION: On this basis, central authorities have decided to keep the core structure of the programme, but to implement several changes. Medical diagnosis and evaluation should replace formal regulating criteria. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356277     DOI: 10.1159/000097935

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  16 in total

1.  The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.

Authors:  Caleb J Banta-Green; Mandy D Owens; Jason R Williams; Jeanne M Sears; Anthony S Floyd; Wendy Williams-Gilbert; Susan Kingston
Journal:  Addict Sci Clin Pract       Date:  2022-07-07

2.  Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.

Authors:  Linn Gjersing; Helge Waal; John R M Caplehorn; Michael Gossop; Thomas Clausen
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

3.  Methadone treatments in a Swiss region, 2001-2008: a registry-based analysis.

Authors:  Thérèse Huissoud; Valentin Rousson; Françoise Dubois-Arber
Journal:  BMC Psychiatry       Date:  2012-12-28       Impact factor: 3.630

4.  Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study.

Authors:  Ivar Skeie; Mette Brekke; Michael Gossop; Morten Lindbaek; Even Reinertsen; Magne Thoresen; Helge Waal
Journal:  BMJ Open       Date:  2011-08-06       Impact factor: 2.692

5.  Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study.

Authors:  Ivar Skeie; Mette Brekke; Morten Lindbaek; Helge Waal
Journal:  BMC Public Health       Date:  2008-01-31       Impact factor: 3.295

6.  A longitudinal study on substance use and related problems in women in opioid maintenance treatment from pregnancy to four years after giving birth.

Authors:  Ingunn O Lund; Håvar Brendryen; Edle Ravndal
Journal:  Subst Abuse       Date:  2014-05-05

7.  Diversity in causes and characteristics of drug-induced deaths in an urban setting.

Authors:  Linn Gjersing; Kristine V Jonassen; Stian Biong; Edle Ravndal; Helge Waal; Jørgen G Bramness; Thomas Clausen
Journal:  Scand J Public Health       Date:  2013-01-09       Impact factor: 3.021

8.  'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'.

Authors:  Ingrid Amalia Havnes; Thomas Clausen; Anne-Lise Middelthon
Journal:  Harm Reduct J       Date:  2013-10-16

9.  A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study.

Authors:  Anne Bukten; Jo Røislien; Svetlana Skurtveit; Helge Waal; Michael Gossop; Thomas Clausen
Journal:  BMC Psychiatry       Date:  2013-10-16       Impact factor: 3.630

10.  Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users.

Authors:  Linn Gjersing; Anne Line Bretteville-Jensen
Journal:  BMC Public Health       Date:  2014-05-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.